Skip to main content
Top
Published in: Current HIV/AIDS Reports 1/2010

01-02-2010

Antiretroviral Adherence Interventions: Translating Research Findings to the Real World Clinic

Authors: Jane M. Simoni, K. Rivet Amico, Laramie Smith, Kimberly Nelson

Published in: Current HIV/AIDS Reports | Issue 1/2010

Login to get access

Abstract

The success of potent combination antiretroviral therapy (ART) for HIV infection is compromised primarily by failure to maintain optimal levels of adherence over the long term. Recent reviews suggest behavioral interventions to promote ART adherence can have significant effects, but these tend to be small and to diminish over time; sustained improvements in biomarkers are particularly elusive. In this article, we update current reviews, focusing specifically on the 13 studies evaluating behavioral interventions to promote ART adherence published since September 2007. We describe the range of intervention strategies employed and qualitatively summarize findings of their efficacy. In conclusion, we consider implications and offer strategies for enhancing adherence in clinic-based HIV care prior to ART initiation, at initiation, and over the course of treatment.
Literature
1.
go back to reference Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Soc Sci Med 2000, 50:1599–1605.CrossRefPubMed Chesney MA, Morin M, Sherr L: Adherence to HIV combination therapy. Soc Sci Med 2000, 50:1599–1605.CrossRefPubMed
2.
go back to reference Williams AB: Adherence to highly active antiretroviral therapy. Nurs Clin North Am 1999, 34:113–129.PubMed Williams AB: Adherence to highly active antiretroviral therapy. Nurs Clin North Am 1999, 34:113–129.PubMed
3.
go back to reference Mannheimer S, Friedland G, Matts J, et al.: The consistency of adherence to an antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002, 34:1115–1121.CrossRefPubMed Mannheimer S, Friedland G, Matts J, et al.: The consistency of adherence to an antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002, 34:1115–1121.CrossRefPubMed
4.
go back to reference Paterson DL, Swindells S, et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133:21–30.PubMed Paterson DL, Swindells S, et al.: Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000, 133:21–30.PubMed
5.
go back to reference Ross L, Lim LM, Wine B, et al.: Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities. HIV Clin Trial 2007, 8:1–8.CrossRef Ross L, Lim LM, Wine B, et al.: Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naïve HIV-infected individuals from 40 United States cities. HIV Clin Trial 2007, 8:1–8.CrossRef
6.
go back to reference Amico KR, Harman JJ, Johnson BT: Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006, 41:285–297.CrossRefPubMed Amico KR, Harman JJ, Johnson BT: Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr 2006, 41:285–297.CrossRefPubMed
7.
go back to reference Simoni JM, Pearson CR, Pantalone DW, et al.: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr December 2006, 43(Suppl 1):S23–S35.CrossRef Simoni JM, Pearson CR, Pantalone DW, et al.: Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: a meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr December 2006, 43(Suppl 1):S23–S35.CrossRef
8.
go back to reference • Amico KR, Harman JJ, O’Grady M, Johnson B: Research synthesis of ART adherence interventions: A synthesis of published adherence intervention outcomes research from 1996 to September. Paper presented at 4th Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care. Miami, FL; April 2009. A meta-analysis of 48 published studies of antiretroviral adherence promotion interventions through September 2007 that systematically considers their efficacy. • Amico KR, Harman JJ, O’Grady M, Johnson B: Research synthesis of ART adherence interventions: A synthesis of published adherence intervention outcomes research from 1996 to September. Paper presented at 4th Annual HIV Treatment Adherence Conference of the International Association of Providers in AIDS Care. Miami, FL; April 2009. A meta-analysis of 48 published studies of antiretroviral adherence promotion interventions through September 2007 that systematically considers their efficacy.
9.
go back to reference • Cote J, Godin G, Ramirez-Garcia P, et al: Program development for enhancing adherence to antiretroviral therapy among persons living with HI. AIDS Patient Care STD 2008, 22:965–975. An excellent example of intervention mapping and its application in the development of theory-based adherence interventions. • Cote J, Godin G, Ramirez-Garcia P, et al: Program development for enhancing adherence to antiretroviral therapy among persons living with HI. AIDS Patient Care STD 2008, 22:965–975. An excellent example of intervention mapping and its application in the development of theory-based adherence interventions.
10.
go back to reference Lester RT, Mills EJ, Kariri A, et al.: The HAART cell phone adherence trial (WelTel Kenya I): a randomized controlled trial protocol. Trials 2009, 10:87–95.CrossRefPubMed Lester RT, Mills EJ, Kariri A, et al.: The HAART cell phone adherence trial (WelTel Kenya I): a randomized controlled trial protocol. Trials 2009, 10:87–95.CrossRefPubMed
11.
go back to reference Nishigaki M, Shimada M, Ideda K, et al.: Process and contents of telephone concultations between registered nurses and clients with HIV/AIDS in Japan. J Assoc Nurses AIDS Care 2007, 18:85–96.CrossRefPubMed Nishigaki M, Shimada M, Ideda K, et al.: Process and contents of telephone concultations between registered nurses and clients with HIV/AIDS in Japan. J Assoc Nurses AIDS Care 2007, 18:85–96.CrossRefPubMed
12.
go back to reference • Hirsch JD, Rosenquist A, Best BM, Miller TA, et al.: Evaluation of the first year of a pilot program in a community pharmacy: HIV/AIDS Medication Therapy Managment for Medi-Cal Beneficiaries. J Manag Care Pharmacy 2009, 15:32–41. This intervention approach was at the level of providing incentives through state funding for pharmacies to adopt more comprehensive approaches to adherence. • Hirsch JD, Rosenquist A, Best BM, Miller TA, et al.: Evaluation of the first year of a pilot program in a community pharmacy: HIV/AIDS Medication Therapy Managment for Medi-Cal Beneficiaries. J Manag Care Pharmacy 2009, 15:32–41. This intervention approach was at the level of providing incentives through state funding for pharmacies to adopt more comprehensive approaches to adherence.
13.
go back to reference Fisher JD, Fisher WA: Theoretical approaches to individual-level change in HIV risk behavior. In Handbook of HIV Prevention. Edited by Peterson R, DiClemente J. New York: Klewer Academic/Plenum; 2000:3–55 Fisher JD, Fisher WA: Theoretical approaches to individual-level change in HIV risk behavior. In Handbook of HIV Prevention. Edited by Peterson R, DiClemente J. New York: Klewer Academic/Plenum; 2000:3–55
14.
go back to reference Fisher JD, Fisher WA, Amico KR, Harman JJ: An information-motivation-behavioral skills model fo adherence to antoretroviral therapy. Health Psychology 2006, 25:262–473.CrossRef Fisher JD, Fisher WA, Amico KR, Harman JJ: An information-motivation-behavioral skills model fo adherence to antoretroviral therapy. Health Psychology 2006, 25:262–473.CrossRef
15.
go back to reference Prochazka JO, DiClemente CC: Stages of change in the modification of problem behaviors. In Progress in Behavior Change Modification. Edited by Herson M, Miller PM, Eisler R. New York: Wadsworth Publishing; 1992:184–218. Prochazka JO, DiClemente CC: Stages of change in the modification of problem behaviors. In Progress in Behavior Change Modification. Edited by Herson M, Miller PM, Eisler R. New York: Wadsworth Publishing; 1992:184–218.
16.
go back to reference Rosenbaum MA: A model for research on self-regulation: reducing the schism between behaviorism and general psychology. In Unifying Behavior Therapy. Edited Eifert GH, Evans IM. New York: Springer Publishing Co.; 1990:126–149. Rosenbaum MA: A model for research on self-regulation: reducing the schism between behaviorism and general psychology. In Unifying Behavior Therapy. Edited Eifert GH, Evans IM. New York: Springer Publishing Co.; 1990:126–149.
17.
go back to reference Sampaio-Sa M, Page-Shafer K, Bangsberg DR, et al.: 100% Adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav 2008, 12:S54–S62.CrossRefPubMed Sampaio-Sa M, Page-Shafer K, Bangsberg DR, et al.: 100% Adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav 2008, 12:S54–S62.CrossRefPubMed
18.
go back to reference Whol AR, Garland WH, Witt MD, et al.: An adherence-focused case management intervention for HIV-positive patients in a public care setting. J HIV/AIDS Social Serv 2009, 8:80–94.CrossRef Whol AR, Garland WH, Witt MD, et al.: An adherence-focused case management intervention for HIV-positive patients in a public care setting. J HIV/AIDS Social Serv 2009, 8:80–94.CrossRef
19.
go back to reference Deering KN, Shannon K, Sinclair H, et al.: Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STD 2009, 23:603–609.CrossRef Deering KN, Shannon K, Sinclair H, et al.: Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STD 2009, 23:603–609.CrossRef
20.
go back to reference Simoni JM, Huh D, Frick PA, et al.: Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled Trial. J Acquir Immune Defic Syndr 2009, 52:499–507. Simoni JM, Huh D, Frick PA, et al.: Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled Trial. J Acquir Immune Defic Syndr 2009, 52:499–507.
21.
go back to reference Pearson CR, Micek MA, Simoni JM, et al.: Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr 2007, 46:238–244.CrossRefPubMed Pearson CR, Micek MA, Simoni JM, et al.: Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. J Acquir Immune Defic Syndr 2007, 46:238–244.CrossRefPubMed
22.
go back to reference DiIorio C, McCarty F, Resnicow K, et al.: Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care 2008, 20:273–283.CrossRefPubMed DiIorio C, McCarty F, Resnicow K, et al.: Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care 2008, 20:273–283.CrossRefPubMed
23.
go back to reference Parsons JT, Colub SA, Rosof E, Holder C: Motivational interviewing and Cognitive-Behavioral interventiont o improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr 2007, 46:443–450.CrossRefPubMed Parsons JT, Colub SA, Rosof E, Holder C: Motivational interviewing and Cognitive-Behavioral interventiont o improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Acquir Immune Defic Syndr 2007, 46:443–450.CrossRefPubMed
24.
go back to reference Reynolds NR, Testa MA, Su M, et al.: Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr 2008, 47:62–68.CrossRefPubMed Reynolds NR, Testa MA, Su M, et al.: Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. J Acquir Immune Defic Syndr 2008, 47:62–68.CrossRefPubMed
25.
go back to reference Johnson MO, Charlebois E, Morin SF, et al.: Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The Healty Living Project randomized controlled study. J Acquir Immune Defic Syndr 2007, 46:574–580.CrossRefPubMed Johnson MO, Charlebois E, Morin SF, et al.: Effects of a behavioral intervention on antiretroviral medication adherence among people living with HIV: The Healty Living Project randomized controlled study. J Acquir Immune Defic Syndr 2007, 46:574–580.CrossRefPubMed
26.
go back to reference Lopez E, Jones DL, Ishii M, et al.: HIV mediation adherence and substance use: The Smartest Women’s Project. Am J Infect Dis 2007, 3:240–247.CrossRefPubMed Lopez E, Jones DL, Ishii M, et al.: HIV mediation adherence and substance use: The Smartest Women’s Project. Am J Infect Dis 2007, 3:240–247.CrossRefPubMed
27.
go back to reference Koenig LJ, Pals SL, Bush T, et al.: Raondomized controlled trila of an interventiont o prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol 2008, 27:159–169.CrossRefPubMed Koenig LJ, Pals SL, Bush T, et al.: Raondomized controlled trila of an interventiont o prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol 2008, 27:159–169.CrossRefPubMed
28.
go back to reference Sabin LL, Bachman DeSilva M, Hamer DH, et al.: Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav 2009 Sept 22 (Epub ahead of print). Sabin LL, Bachman DeSilva M, Hamer DH, et al.: Using electronic drug monitor feedback to improve adherence to antiretroviral therapy among HIV-positive patients in China. AIDS Behav 2009 Sept 22 (Epub ahead of print).
29.
go back to reference • Simoni JS, Amico KR, Pearson CR, Malow RM: Strategies for promoting adherence to antiretroviral therapy: a review of the liteature. Curr Infect Dis Rep 2008, 10:515–521. This is a qualitative review of adherence intervention studies that highlights some of the most recent and innovative research in the areas of patient education and case management, modified early direct observed therapy, contingency management, and interventions emphasizing social support. • Simoni JS, Amico KR, Pearson CR, Malow RM: Strategies for promoting adherence to antiretroviral therapy: a review of the liteature. Curr Infect Dis Rep 2008, 10:515–521. This is a qualitative review of adherence intervention studies that highlights some of the most recent and innovative research in the areas of patient education and case management, modified early direct observed therapy, contingency management, and interventions emphasizing social support.
30.
go back to reference Sandelowski M, Voils CI, Chang Y, Lee E: A systematic review comparing antiretroviral adherence descriptive intervention studies conducted in the USA. AIDS Care 2009, 21:953–966.CrossRefPubMed Sandelowski M, Voils CI, Chang Y, Lee E: A systematic review comparing antiretroviral adherence descriptive intervention studies conducted in the USA. AIDS Care 2009, 21:953–966.CrossRefPubMed
31.
go back to reference Segal-Isaacson CJ, Tobin JN, Weiss SM, et al.: Improving dietary habits in disadvantaged women with HIV/AIDS: The SMART/EST Women’s Project. AIDS Behav 2006, 10:659–670.CrossRefPubMed Segal-Isaacson CJ, Tobin JN, Weiss SM, et al.: Improving dietary habits in disadvantaged women with HIV/AIDS: The SMART/EST Women’s Project. AIDS Behav 2006, 10:659–670.CrossRefPubMed
Metadata
Title
Antiretroviral Adherence Interventions: Translating Research Findings to the Real World Clinic
Authors
Jane M. Simoni
K. Rivet Amico
Laramie Smith
Kimberly Nelson
Publication date
01-02-2010
Publisher
Current Science Inc.
Published in
Current HIV/AIDS Reports / Issue 1/2010
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-009-0037-5

Other articles of this Issue 1/2010

Current HIV/AIDS Reports 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.